Moderna's first mRNA drug factory in China starts construction
因醉鞭名马幌
发表于 2023-11-28 20:19:40
299
0
0
On November 28, Moderna, a manufacturer of COVID-19 vaccine, said that the company started to build its first mRNA drug production plant in China this month. It is understood that the COVID-19 vaccine produced by Moderna has not yet been approved in the Chinese market, but the company said in July that it has signed an agreement with the Shanghai Municipal Government, the financial center of China, to strive for opportunities to research, develop and produce mRNA drugs in China.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Honda accelerates its electrification layout in China, with joint ventures intensively deploying electric vehicles
- Will it come true? The first institution to predict the Fed's suspension of interest rate cuts in December appears
- OpenAI poaching cryptocurrency company Coinbase hires its first Chief Marketing Officer
- Merck PD-1 inhibitor pembrolizumab's fourth lung cancer indication approved in China
- The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
- The delivery network covers about 2200 cities and towns. Yum! China participated in the 2nd Chain Expo for the first time
- The CEO of the world's fourth largest car company, Stellantis, has resigned and adjusted the person in charge of related business in China
- Nvidia expands in China against the trend, attracting talent and adding hundreds of R&D personnel in one year
- Apple is rumored to have preliminary discussions with Tencent and ByteDance to consider embedding their AI models into iPhones sold in China
- Sanofi's BTK inhibitor is declared for market in China
